Andina Capital Management LLC Acquires New Shares in Option Care Health, Inc. $OPCH

Key Points

Error: Response status code does not indicate success: 429 (Too Many Requests).

Andina Capital Management LLC purchased a new position in shares of Option Care Health, Inc. (NASDAQ:OPCH - Free Report) during the first quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor purchased 14,685 shares of the company's stock, valued at approximately $513,000.

A number of other institutional investors and hedge funds also recently bought and sold shares of the business. Fuller & Thaler Asset Management Inc. increased its stake in Option Care Health by 30.8% during the first quarter. Fuller & Thaler Asset Management Inc. now owns 4,204,481 shares of the company's stock worth $146,947,000 after purchasing an additional 989,048 shares during the period. Brooklyn Investment Group grew its position in shares of Option Care Health by 186.6% during the first quarter. Brooklyn Investment Group now owns 1,198 shares of the company's stock worth $42,000 after buying an additional 780 shares in the last quarter. Prospector Partners LLC grew its position in shares of Option Care Health by 22.9% during the first quarter. Prospector Partners LLC now owns 111,200 shares of the company's stock worth $3,886,000 after buying an additional 20,700 shares in the last quarter. Versor Investments LP grew its position in shares of Option Care Health by 191.8% during the first quarter. Versor Investments LP now owns 56,900 shares of the company's stock worth $1,989,000 after buying an additional 37,400 shares in the last quarter. Finally, Raymond James Financial Inc. grew its position in shares of Option Care Health by 110.7% during the first quarter. Raymond James Financial Inc. now owns 184,074 shares of the company's stock worth $6,433,000 after buying an additional 96,719 shares in the last quarter. 98.05% of the stock is currently owned by hedge funds and other institutional investors.

Option Care Health Stock Performance

OPCH traded up $0.90 during trading on Friday, hitting $28.74. 2,369,675 shares of the stock were exchanged, compared to its average volume of 1,937,741. The firm has a market capitalization of $4.66 billion, a P/E ratio of 22.99, a PEG ratio of 1.76 and a beta of 0.79. Option Care Health, Inc. has a 1-year low of $21.39 and a 1-year high of $35.53. The stock has a fifty day moving average price of $29.92 and a two-hundred day moving average price of $31.75. The company has a quick ratio of 1.00, a current ratio of 1.52 and a debt-to-equity ratio of 0.81.

Option Care Health (NASDAQ:OPCH - Get Free Report) last released its quarterly earnings results on Wednesday, July 30th. The company reported $0.41 EPS for the quarter, topping the consensus estimate of $0.40 by $0.01. Option Care Health had a return on equity of 17.53% and a net margin of 3.93%.The company had revenue of $1.42 billion for the quarter, compared to analyst estimates of $1.35 billion. During the same quarter in the previous year, the company posted $0.30 earnings per share. The firm's revenue was up 15.4% compared to the same quarter last year. Option Care Health has set its FY 2025 guidance at 1.650-1.720 EPS. As a group, sell-side analysts predict that Option Care Health, Inc. will post 1.22 earnings per share for the current year.

Analysts Set New Price Targets

A number of equities analysts have recently commented on OPCH shares. Citigroup reissued an "outperform" rating on shares of Option Care Health in a research report on Thursday, July 31st. JMP Securities boosted their price objective on Option Care Health from $36.00 to $38.00 and gave the stock a "market outperform" rating in a research report on Thursday, July 31st. UBS Group raised Option Care Health from a "neutral" rating to a "buy" rating and boosted their price objective for the stock from $38.00 to $40.00 in a research report on Wednesday, April 30th. Finally, Barrington Research reissued an "outperform" rating and set a $38.00 price objective on shares of Option Care Health in a research report on Thursday, July 10th. Eight equities research analysts have rated the stock with a Buy rating and one has issued a Hold rating to the company's stock. Based on data from MarketBeat.com, the stock has a consensus rating of "Moderate Buy" and a consensus target price of $35.75.

Insider Activity at Option Care Health

In related news, Director Harry M. Jansen Kraemer, Jr. bought 36,000 shares of the stock in a transaction on Wednesday, August 20th. The shares were bought at an average cost of $27.15 per share, for a total transaction of $977,400.00. Following the purchase, the director owned 375,390 shares of the company's stock, valued at $10,191,838.50. This trade represents a 10.61% increase in their position. The acquisition was disclosed in a document filed with the SEC, which is accessible through the SEC website. Also, Director Timothy P. Sullivan bought 20,000 shares of the stock in a transaction on Thursday, August 21st. The stock was bought at an average price of $27.51 per share, for a total transaction of $550,200.00. Following the completion of the purchase, the director directly owned 49,229 shares in the company, valued at approximately $1,354,289.79. The trade was a 68.43% increase in their position. The disclosure for this purchase can be found here. Company insiders own 0.64% of the company's stock.

Option Care Health Profile

Option Care Health, Inc offers home and alternate site infusion services in the United States. The company provides anti-infective therapies; home infusion services to treat heart failures; home parenteral nutrition and enteral nutrition support services for numerous acute and chronic conditions, such as stroke, cancer, and gastrointestinal diseases; immunoglobulin infusion therapies for the treatment of immune deficiencies; and treatments for chronic inflammatory disorders, including crohn's disease, plaque psoriasis, psoriatic arthritis, rheumatoid arthritis, ulcerative colitis, and other chronic inflammatory disorders.